ACQUISITION OF INTOUCH PHARMACY LLC (Tables)

9 Months Ended

Sep. 30, 2019

ACQUISITION OF INTOUCH PHARMACY LLC

Schedule of consideration transferred to acquire InTouch

Cash	$	7,491
Restricted common stock (836,431 shares)		3,899
Contingent consideration at fair value		7,102
	$	18,492

Schedule of estimated fair values of the assets acquired and liabilities assumed

Cash	$	443
Receivables		6,939
Inventories		496
Other current assets		40
Definite-lived intangibles assets		6,660
Other noncurrent assets		24
Accounts payable		(2,567)
Accrued expenses - compensation and benefits		(625)
Total identifiable net assets		11,410
Goodwill		7,082
	$	18,492

Schedule of estimated fair value of the definite-lived intangible assets

	Useful
	Life	Amount
Patient relationships	8 years	$	4,400
Non-compete employment agreements	5 years		260
Trade names and trademarks	5 years		2,000
		$	6,660